Get the Stockscreener App
2.89
3.34%
-0.10
After Hours:
2.81
-0.08
-2.77%
Alaunos Therapeutics Inc stock is traded at $2.89, with a volume of 21,610.
It is down -3.34% in the last 24 hours and down -12.42% over the past month.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
See More
Previous Close:
$2.99
Open:
$2.97
24h Volume:
21,610
Relative Volume:
1.26
Market Cap:
$6.87M
Revenue:
$5,000
Net Income/Loss:
$-4.18M
P/E Ratio:
-1.2867
EPS:
-2.2461
Net Cash Flow:
$-2.97M
1W Performance:
-0.69%
1M Performance:
-12.42%
6M Performance:
-9.40%
1Y Performance:
-0.34%
1-Day Range:
$2.88
$3.02
1-Week Range:
$2.7794
$3.14
52-Week Range:
$1.67
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Name
Alaunos Therapeutics Inc
Sector
Industry
Phone
(346) 355-4099
Address
501 E LAS OLAS BLVD, FORT LAUDERDALE
Compare TCRT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
2.89 | 7.11M | 5,000 | -4.18M | -2.97M | -2.2461 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Resumed | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Stock (TCRT) Latest News
Alaunos Therapeutics receives Nasdaq notice for non-compliance with equity rule - Investing.com
Alaunos Therapeutics Faces Nasdaq Non-Compliance, Delisting Risk - TipRanks
Alaunos Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets
Aug Update: How does Alaunos Therapeutics Inc correlate with Nasdaq2026 Market WrapUp & Long Hold Capital Preservation Plans - baoquankhu1.vn
TCRT Technical Analysis & Stock Price Forecast - Intellectia AI
TCRT PE Ratio & Valuation, Is TCRT Overvalued - Intellectia AI
Ziopharm: Q4 Earnings Snapshot - 10TV
Alaunos Therapeutics 10-K: Revenue $0.005M, Net loss $4.176M - TradingView — Track All Markets
Cash runway, Nasdaq risks and obesity focus at Alaunos (TCRT) - Stock Titan
Inflation Data: Should value investors consider Alaunos Therapeutics IncQuarterly Investment Review & Community Consensus Trade Signals - baoquankhu1.vn
Weight loss data from obese mice looks promising for Alaunos Therapeutics, but shares drop - MSN
Aug Update: Is Alaunos Therapeutics Inc a cyclical or defensive stockTrend Reversal & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Contrasting Xeris Biopharma (NASDAQ:XERS) and Alaunos Therapeutics (NASDAQ:TCRT) - Defense World
TCRT,MLAC Revenue Breakdown - Finviz
Decliners Report: Can Alaunos Therapeutics Inc stock double in the next year2026 Trading Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
Aug Patterns: Is Alaunos Therapeutics Inc forming a bullish divergence2026 Dividend Review & Weekly Setup with High ROI Potential - baoquankhu1.vn
Short Interest in Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Decreases By 14.3% - Defense World
Shareholder group in Alaunos Therapeutics (TCRT) proposes $7M control-shifting investment - Stock Titan
Will Alaunos Therapeutics Inc benefit from rate cutsJuly 2025 Macro Moves & Safe Capital Growth Plans - baoquankhu1.vn
Alaunos reports early obesity drug data from mouse studies - Investing.com South Africa
TCRT SEC FilingsAlaunos Therapeutics, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Weight Loss Data From Obese Mice Looks Promising For Alaunos Therapeutics, But Shares Drop - Benzinga
Alaunos reports findings with ALN-1003 in DIO mouse model - bioworld.com
Alaunos Reports Positive Preclinical Data for Obesity Candidate - TipRanks
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders - The Manila Times
Alaunos Therapeutics reports positive preclinical ALN1003 data showing dose-dependent weight loss, liver improvements - TradingView
Non-hormonal obesity pill helps mice lose weight, improve liver health - Stock Titan
TCRT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Investors seek $7M Alaunos (TCRT) private placement and board seat - Stock Titan
MSN Money - MSN
Short Interest in Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Drops By 14.6% - Defense World
Chart Watch: Can Alaunos Therapeutics Inc stock double in the next yearJuly 2025 Price Swings & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Will Alaunos Therapeutics Inc. face regulatory challengesMarket Volume Summary & Fast Moving Stock Trade Plans - mfd.ru
How does Alaunos Therapeutics Inc. correlate with NasdaqJuly 2025 Reactions & Precise Buy Zone Tips - mfd.ru
Will Alaunos Therapeutics Inc. stock see PE expansion2025 Market WrapUp & Real-Time Buy Signal Alerts - mfd.ru
Published on: 2026-02-11 00:02:19 - baoquankhu1.vn
Alaunos Therapeutics Pivots to Obesity Drug Development in Race Against Time - AD HOC NEWS
Buybacks Report: Is Alaunos Therapeutics Inc a turnaround storyWeekly Earnings Recap & High Win Rate Trade Tips - baoquankhu1.vn
S P Trends: Should value investors consider Alaunos Therapeutics Inc.2025 Key Lessons & Stepwise Trade Signal Guides - mfd.ru
Swing Trade: Is Alaunos Therapeutics Inc a turnaround story2025 Price Targets & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Can Alaunos Therapeutics Inc stock double in the next year - baoquankhu1.vn
Is Alaunos Therapeutics Inc a cyclical or defensive stockTrade Ideas & High Accuracy Swing Trade Signals - baoquankhu1.vn
Fundamentals Check: truyen hinh quan khu mot ky 1 thang 11 ngay 11112019 1087 1July 2025 Market Mood & Low Volatility Stock Suggestions - baoquankhu1.vn
Published on: 2026-01-22 06:26:50 - baoquankhu1.vn
Why Alaunos Therapeutics Inc. stock could see breakout soonJuly 2025 Outlook & Advanced Swing Trade Entry Alerts - bollywoodhelpline.com
Volume Report: Is BioSig Technologies Inc a turnaround storyJuly 2025 Review & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Downgrade Watch: Will Alaunos Therapeutics Inc benefit from rate cutsQuarterly Portfolio Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Why Alaunos Therapeutics Inc. stock could rally in 2025Trade Analysis Report & AI Driven Price Predictions - ulpravda.ru
Market Wrap: Why Alaunos Therapeutics Inc stock is favored by pension fundsJuly 2025 Final Week & AI Optimized Trade Strategies - Bộ Nội Vụ
Published on: 2026-01-09 20:19:14 - Улправда
Alveus debuts in obesity arena with $160m Series A - Pharmaceutical Technology
Alaunos Therapeutics Inc Stock (TCRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):